Is It Time to Buy Marijuana Stocks?
The Motley Fool
Published Dec 08, 2018 19:25
Updated Dec 08, 2018 19:45
How quickly things change in the marijuana industry and with marijuana stocks.
After another week of marijuana stocks getting decimated, many investors are surely wondering if now is the time to establish positions in order to get exposure to this new and exciting business.
Canopy Growth Corp (TSX:WEED)(NYSE:CGC) stock has increased more than 300% since the fall of 2017 and 23% year-to-date.
But those investors who have gotten in more recently are down big, as the stock has plummeted 40% from highs of this summer, and down 8% in the last week.
Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) stock has increased 170% relative to 2017, 13% since last year, and declined 50% from its summer highs.
Finally, Aphria Inc (TSX:APHA)(NYSE:APHA) stock has risen only 13% relative to the fall of 2017, fallen 44% versus a year ago, and plummeted a whopping 62% from summer highs.
The speculative nature of these stocks come to life when we do this price review.
And in a new development this week, we have the short seller report on Aphria, alleging that the company’s international acquisitions are worthless and were done to benefit insiders.
This report and the market’s reaction is partly a reflection of the lack of visibility and uncertainties that exist in this new and emerging industry one that we can all agree is not only relevant, but also ultimately make money, albeit it is currently mired in speculating investors, lofty valuations, heavy growth spending, and an all-around lack of visibility.
I am still staying on the sidelines, awaiting a reduction in the risk profile of these stocks, and better visibility.
A different way to get exposure
And then on Friday, U.S. cigarette maker Altria Group (NYSE:MO) Inc. (TSX:CRON) (NYSE:CRON), in a $1.8 billion investment that will give Altria 45% ownership of the company, bringing life back into marijuana stocks.
Altria is counting on this move to help it combat the continued decline in cigarette sales.
Chronos stock rallied approximately 20% on this announcement, as it is yet another vote of confidence for the industry and the company.
As expected, other marijuana stocks on the TSX rallied off of this news.
Get The App
Personally, for the time being at least, I would rather participate in the marijuana upside by buying a more developed company such as Altria, a dividend stock currently yielding 5.78%, and trading at under 15 times this year’s earnings.
Yes, the upside is not as high, but the downside risk is also not as big, and the volatility and seemingly random stock price movements will not be an issue. That would be a trade-off I would be willing to accept.
Fool contributor Karen Thomas has no position in any of the stocks mentioned.
This Article Was First Published on The Motley Fool
Written By: The Motley Fool
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.